(Q37411168)

20 August 2017

1 reference

title

Concurrent chemotherapy and radiotherapy for head and neck cancer (English)

1 reference

20 August 2017

0 references

1 reference

Ryan J Burri

1

1 reference

PubMed ID

19275508

20 August 2017

Nancy Y Lee

series ordinal

2

1 reference

20 August 2017

1 March 2009

1 reference

Expert Review of Anticancer Therapy

20 August 2017

1 reference

20 August 2017

9

1 reference

20 August 2017

3

1 reference

20 August 2017

293-302

1 reference

20 August 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Estimates of the worldwide incidence of eighteen major cancers in 1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Biological basis for chemo-radiotherapy interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Investigation of relationship between change in locoregional control and change in overall survival in randomized controlled trials of modified radiotherapy in head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiothera

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.293

21 January 2018

Identifiers

DOI

10.1586/14737140.9.3.293

1 reference

20 August 2017

1 reference

PubMed ID

19275508